Dendreon Corp fka DNDNQ

[Bio_Tech_Boss]

Ocyanblue, thanks for the continued excellent contributions.

I will, however, offer a cautionary note about relying on Monique's representations when discussing the P-11 trial:

When discussing the P-11 trial with Monique several months ago, she told me that the P-11 end point was Time to PSA doubling, which of course is grossly wrong. I had to send her the slides showing the actual endpoints in order to convince her that the endpoint was not Time To PSADT.

Luck to all,

BTB